Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1168 of 5804
-
New flu pill shows promise for teens in Late-Stage trial
Symptom relief OngoingThis trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New drug KESONOTIDE™ enters human trials for multiple cancers
Disease control Recruiting nowThis clinical trial is an adaptive study of a novel vimentin inhibitor in cancers. It is an open label, multicentre, single ascending dose level in phase I and cohort exploration in phase II. Primary objective is to evaluate safety and tolerability of KESONOTIDE™ as a monothera…
Phase: PHASE1, PHASE2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New shot for eczema shows promise in early trial
Disease control Recruiting nowThis trial was designed to evaluate the efficacy and safety of SHR-1905 in patients with moderate-to-severe atopic dermatitis.
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy aims to boost survival in elderly lung cancer patients
Disease control Recruiting nowThe use of neoadjuvant immuno-chemotherapy could improve survival outcomes of patients eligible for sequential radio-chemotherapy comparing to the benefit already obtained with maintenance immunotherapy.
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Heart mapping study could personalize AFib ablation and reduce repeat procedures
Knowledge-focused Recruiting nowAtrial fibrillation (AF) is the most common heart rhythm disorder, affecting millions worldwide and causing symptoms such as palpitations, fatigue and breathlessness. It also increases the risk of stroke and heart failure, so effective treatment is essential. A treatment for AF …
Phase: NA • Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Could a portable MRI bring brain scans to remote areas?
Diagnosis Recruiting nowMobile imaging diagnostic devices are extremely valuable for clinical diagnosis both inside and outside healthcare facilities. However, Magnetic Resonance Imaging (MRI)-the gold standard for diagnosing many neurological and musculoskeletal conditions-is not easily portable. Moreo…
Phase: NA • Sponsor: Instituto de Investigacion Sanitaria La Fe • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Dengue vaccine gets a makeover: new formula tested in phase 3 trial
⭐️ VACCINE ⭐️ OngoingDengue fever is caused by an infection with the dengue virus. Vaccination with Dengue Tetravalent Vaccine (TDV) can help prevent dengue fever. The TDV in current formulation has been approved by health authorities in many countries around the world. The main aim of the study is t…
Phase: PHASE3 • Sponsor: Takeda • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 19, 2026 00:00 UTC
-
Can starting a new rescue inhaler in the ER keep asthma patients out of the hospital?
Disease control Recruiting nowThe study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a simple supplement boost brain function in Parkinson's?
Disease control Recruiting nowThe goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation. The main ques…
Phase: PHASE1, PHASE2 • Sponsor: Prabesh Kanel • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New shot could ease knee pain for millions with arthritis
Symptom relief Recruiting nowA Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Phase: PHASE3 • Sponsor: Saol Therapeutics Inc • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New hope for advanced cancer patients: first human trial of SIM0609 begins
Disease control Recruiting nowThis is an open-label,multicenter phase I study to evaluate the safety,Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0609 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New COPD pill aims to cut Flare-Ups in half
Disease control Recruiting nowThe goal of this clinical trial is to learn if drug JKN2403 works to treat moderate-to-severe COPD in adults. It will also learn about the safety and pharmacokinetic characteristics of drug JKN2403. The main questions it aims to answer are: Does drug JKN2403 reduce the incidence…
Phase: PHASE2 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for tough lung cancers: experimental drug targets immunotherapy failures
Disease control Recruiting nowTo learn if SAR445877 can help to control locally advanced or metastatic NSCLC in patients who have previously received ICI therapy.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo aims to outsmart brain Cancer's defenses
Disease control Recruiting nowPreclinical data have demonstrated the combination of azeliragon, a RAGE inhibitor, with radiation therapy (RT) can effectively reduce immune-suppressive myeloid cells and restore T-cell activation to improve tumor control in murine glioma models. Ongoing clinical studies of azel…
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New bladder cancer drug shows promise in early trial
Disease control Recruiting nowThe purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called sasanlimab. This study is for adults who have a type of bladder cancer that has…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Dialysis patients may get heart boost from exercise with blood flow cuffs
Disease control Recruiting nowThe main objective is to evaluate in hemodialysis patients the effects of two intradialytic rehabilitation programs based on physical exercise, with or without the application of blood flow restriction, on myocardial stunning and morpho-functional cardiac remodelling, compared wi…
Phase: NA • Sponsor: University of Avignon • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could special gloves save more lives during cardiac arrest?
Disease control OngoingCardiopulmonary arrest is the sudden cessation of spontaneous breathing and circulation due to various causes. Cardiopulmonary resuscitation (CPR) is the set of decisions and procedures encompassing all efforts aimed at restoring spontaneous circulation. Guidelines are published …
Phase: NA • Sponsor: Izmir Katip Celebi University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a single dose of ketamine during surgery cut opioid use and PTSD?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if ketamine, given during surgery, can help improve recovery for adults with serious orthopedic trauma. The study will test whether ketamine reduces pain, lowers the need for opioids, and improves mental health outcomes like depression …
Phase: PHASE4 • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to boost breast cancer remission before surgery
Disease control Recruiting nowTriple-negative breast cancer (TNBC) accounts for about 20% of breast cancers, is poorly differentiated, progresses rapidly, and frequently recurs, making it the subtype with the worst prognosis. Owing to the absence of actionable receptors on tumor cells, chemotherapy has histor…
Phase: PHASE1 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New antibody aims to cut lung attacks in bronchiectasis patients
Disease control Recruiting nowAZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC